New precision therapy offers hope for those with hard-to-treat cancer 

 Chris Russell, a 55-year-old father-of-four from Mayfield in Derbyshire, who was diagnosed with CUP in early 2022 after nearly a year of specialists trying to find out what was wrong with him. A new precision therapy has shown 'encouraging' results for patients with a traditionally hard-to-treat cancer. Picture: PA

A new precision therapy has shown "encouraging" results for patients with a traditionally hard-to-treat cancer.

Scientists said a new molecular-targeted treatment can help increase "progression-free survival" rates for patients with cancer of unknown primary (CUP).